Good afternoon, and welcome to the Evoke Pharma fourth quarter and full-year 2024 earnings conference call. (Operator Instructions) Please be advised that today's call is being recorded. I would now ...
1d
Evoke Pharma Inc (EVOK) nearly doubles its annual revenue, reduces net loss, and outlines ambitious growth strategies for ...
Evoke Pharma, Inc. ( NASDAQ: EVOK) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Daniel Kontoh-Boateng – DKB Partners Matt D’Onofrio – Chief Executive Officer Chris Quesenberry – Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback